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Microtubules are dynamic structures, and their assembly is regulated by phosphoproteins called
microtubule-associated proteins (MAPs). We propose that striatin, a protein belonging to the stria-
tin family of proteins, is involved in regulation of microtubules. In HEK293T cells, striatin colocalizes
with microtubules and stably associates with PP2Ac. Inhibition of striatin expression results in
hyperphosphorylation of MAP2 and destabilizes microtubules. Striatin-induced destabilization of
microtubules inhibited the proliferation of HEK293T cells and caused the accumulation of cells in
the G0/G1 phase of the cell cycle. These results suggest that the PP2A/striatin complex modulates
microtubule dynamics by regulating MAP2 phosphorylation.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The striatin family consists of 3 multidomain proteins: striatin,
SG2NA and zinedin. These proteins are encoded by different genes
but show high degrees of homology in both the amino acid
sequence and the domain structure. All three striatin family mem-
bers bind calmodulin in the presence of calcium ions [1] and inter-
act directly with caveolin [2]. This indicates that they are involved
in calcium-dependent signaling pathways. The prototypic member
– striatin – was originally discovered in brain tissue (particularly
the striatum, hence its name), where it is expressed most abun-
dantly. Striatin can also be detected in cells of other tissues and
organs, including liver, skeletal muscles, heart, kidney, liver, testes,
lymphocytes or ﬁbroblasts. This indicates that the biological func-
tions of striatin are not limited to neuronal cells but rather are
more widespread. Striatin is composed of 780 aa that form four
protein–protein interaction domains. Starting from the N-termi-
nus, these are a caveolin-binding domain, a coiled-coil binding
domain, a Ca2+-calmodulin binding domain, and eight WD repeats[3]. WD repeats form a characteristic beta propeller structure that
serves as a platform for interaction with other proteins [4]. The
presence of diverse protein–protein interaction domains in striatin
and the other members of striatin family, SG2NA and zinedin, sug-
gests that they may act as scaffolds to organize multiprotein com-
plexes. Proteomic analysis of striatin complexes revealed the
presence of protein phosphatase 2A (PP2A) [5] and germinal center
kinase III (GCKIII) [6]. Therefore, they have been named striatin-
interacting phosphatase and kinase (STRIPAK) complexes. Increas-
ing amounts of data indicate that STRIPAK complexes (and there-
fore, either directly or indirectly, striatins) regulate a variety of
cellular processes including cell signaling, cell-cycle control, apop-
tosis, Golgi assembly, cell migration and cell polarity. STRIPAK
complexes are also involved in neural and vascular development
and in several disease conditions [7].
The identiﬁcation of proteins that interact with striatin has sig-
niﬁcantly improved the understanding of the biological functions
of striatin family members. Association with a phocein suggests
that striatin may regulate membrane trafﬁcking, intracellular
vesicular transport, clathrin-dependent endocytosis and microtu-
bule organization [8–10]. Striatins also associate with mammalian
MOB1 (Mps One Binder), which regulates the cell cycle and ploidy
of dividing cells [11]. Yeast MOB1 is involved in the cytoskeleton
J. Kaz´mierczak-Baran´ska et al. / FEBS Letters 589 (2015) 222–230 223reorganization during cytokinesis, indicating that striatin may play
a role in regulating the cytoskeleton [12]. Striatin also participates
in non-genomic effects of ERa signaling and the regulation of tight
junctions [13,14].
The association of striatin(s) with PP2A is particularly interest-
ing because PP2A dephosphorylates multiple proteins and thus
regulates a wide variety of cellular processes. PP2A is a major ser-
ine/threonine phosphatase expressed in all eukaryotic cells, and it
regulates key biological processes such as viral transformation,
development, neuronal signaling and cell-cycle regulation. Func-
tional PP2A comprises a catalytic C subunit (36kDa) and a struc-
tural A subunit (PR65/A, 65kDa), which form a stable core dimer.
This core dimer can further associate with the third subunit (B),
that confers a speciﬁc cellular localization and substrate speciﬁcity
to the PP2A trimeric holoenzyme [15]. To date, 23 different B sub-
units have been identiﬁed, and they can be classiﬁed into four pro-
tein families: PR55/B, PR56/61/B0, PR48/59/72/130/B00 and the
recently identiﬁed PR93/PR110/B000. The PR93/PR110/B000 family
consists of striatin and SG2NA. Both proteins have been shown to
directly interact with the PP2A core dimer [5]. This indicates that
striatin(s) may be at least indirectly involved in the regulation of
cellular processes that depend on phosphorylation/dephosphoryla-
tion events. This may be achieved by targeting the PP2A core dimer
to speciﬁc protein substrates and/or intracellular locations. Inter-
estingly, PP2A also orchestrates the organization of the cytoskele-
ton via particular microtubules, through regulating the
phosphorylation of microtubule-associated proteins (MAPs). MAPs
comprise the heterogeneous proteins that can bind microtubules
and modulate their assembly, dynamics and stability. MAPs con-
tain many phosphorylation sites, and it is well established that
the balance between MAP phosphorylation and dephosphorylation
governs their binding to and stabilization of MTs in vivo. Studies in
Xenopus eggs demonstrated that during mitosis, the phosphatase
activity of PP2A is required for the maintenance of short MTs. This
was attributed to the control of the phosphorylation state of Op18/
stathmin by PP2A. Dephosphorylation of Op18/stathmin leads to
an increase in microtubule catastrophes and thus to shorter MT
polymers [16]. PP2A also dephosphorylates the microtubule-asso-
ciated proteins tau and MAP2, which play key roles in the regula-
tion of MT organization in neurons. PP2A/Ba has been shown to
bind and dephosphorylate tau, leading to MT stabilization [17,18].
MAP2 is encoded by a single gene, but because there are multi-
ple splice variants, several MAP2 protein isoforms exist. The high-
molecular-weight (HMW) isoforms MAP2a and MAP2b have
molecular masses of 280 and 270kDa, respectively. The low-molec-
ular-weight (LMW) isoforms MAP2c and MAP2d have molecular
masses of 70 and 75kDa, respectively [19]. MAP2 is mostly
expressed in neuronal cells, but it has also been detected in other
tissues, including skeletal muscle, epithelial tissues and testis
[20]. The major function of MAP2 is the stabilization and promo-
tion of MT assembly and elongation through binding to microtu-
bules. MAP2 binds reversibly to MTs, and this process is
regulated by the phosphorylation/dephosphorylation of MAP2
Ser/Thr residues. Hyperphosphorylation of MAP2 leads to its disso-
ciation from MTs and induces their disassembly. Conversely, the
dephosphorylation of MAP2 enhances its binding to MTs and
increases the assembly rate and stability of MTs [21]. MAP2 is
phosphorylated by various kinases, including PKA, PKC, CAMKII,
ERKs, GSK3, CDKs and MARKs. This suggests that MAP2 function
is regulated by many signaling pathways activated in response to
different intra- and/or extracellular signals. Much less is known
about the regulation of MAP2 dephosphorylation. Several in vitro
studies have shown that phosphorylated MAP2 is a substrate for
the cellular phosphatases PP1, PP2A and PP2B (calcineurin) [19].
This indicates that these phosphatases may regulate the biological
functions of MAP2. It has been demonstrated that the PR55/Bavariable subunit of the PP2A holoenzyme is involved in the regula-
tion of MAP2 phosphorylation. PR55/Ba directly binds MAP2; upon
this interaction, MAP2 is dephosphorylated by the associated PP2A
catalytic subunit [22].
Here, we provide evidence that striatin, through its association
with the PP2A catalytic subunit, may also regulate MAP2 phos-
phorylation. Our data indicate that striatin colocalizes with micro-
tubules in HEK293T cells. Moreover, downregulation of striatin
leads to increased phosphorylation of MAP2 and depolymerization
of microtubules. As a result of MT destabilization, we observed the
inhibition of HEK293T proliferation and the accumulation of cells
in the G0/G1 phase of the cell cycle.
2. Materials and methods
2.1. Immunoﬂuorescence microscopy
HEK293T cells were plated on glass coverslips coated with 1% L-
lysine (Sigma) in 24-well plate and cultured in a complete medium
to a conﬂuency of about 80%. Then culture medium was removed
and cells were washed once with PBS and ﬁxed with 1% formalde-
hyde/PBS for 10 min at room temperature. After ﬁxation samples
were washed once with PBS and permeabilized with 0.2% Triton
X-100 in PBS for 10 min at room temperature. Subsequently, cells
were blocked with 5% BSA in PBS for 1 h at 37 C. Microtubules
were visualized with rabbit monoclonal antibodies for b-tubulin
(clone 9F3) conjugated with AlexaFluor 555 (1:200 in 0.5%BSA/
PBS, Cell Signaling) by overnight incubation at 4 C. Cells were
washed 4–5 times with PBS and incubated with primary mouse
mAb to striatin (2.5 lg/ml in 0.5%BSA/PBS, BD Pharmingen) for
2 h at 37 C. Cells were washed 4–5 times with PBS and incubated
with goat anti-mouse IgG conjugated with AlexaFluor 488 (2 lg/ml
in 0.5%BSA/PBS, Invitrogen) for 45 min at 37 C. After extensive
washing the coverslips were mounted on glass slides using PBS/
glycerol (Citiﬂuor, London). As a control, HEK293T incubated with
primary mouse isotype IgG (2.5 lg/ml in 0.5%BSA/PBS, 2 h at 37 C)
followed by goat-anti mouse IgG conjugated with AlexaFluor 488
(2 lg/ml in 0.5%BSA/PBS, 45 min at 37 C) were used. Images were
taken using a confocal laser scanning microscope, Nikon D-Eclipse
C1 with Plan Apochromat 60.0x/1.40/0.13 oil immersion objective
and analyzed with EZ-C1 version 3.6 software (Nikon, Japan).
2.2. Cell cycle analysis
70  104 HEK 293T cells were seeded on 6-well plate. 24 h later,
cells were transfected with separate STRN siRNA at the concentra-
tion of 150 nM. Cells were also transfected simultaneously with
the mixture of siRNAs for STRN, SG2NA and ZIN (mix V1) at the
concentration of 180 nM. 48 h post transfection cells were washed
2 with PBS, trypsinized and washed again 2 with PBS. Cells
were ﬁxed overnight in 70% ethanol/PBS at 20 C. Fixed cells were
washed 2 with PBS and incubated with RNase A (ﬁnal conc.
60 lg/ml) at 37 C for 30 min. Next, propidium iodide (Sigma)
was added to a cell suspension (ﬁnal conc. 10 lg/ml) and incu-
bated for 30 min at room temperature in the dark. Subsequently,
10  103 of cells were analyzed on ﬂow cytometer (FACS Calibur,
BD Biosciences). Cell cycle analysis was performed using ModFit
LT 3.2 software.
2.3. Cell proliferation
20  103 HEK293T cells were seeded on each well on 96-well
plate (Nunc). 24 h later cells were transfected with siRNAs in the
presence of Lipofectamine2000 (Invitrogen) according to manufac-
turer’s instructions. The ﬁnal concentration of the siRNA was
150 nM for single siRNA transfections or 180 nM for simultaneous
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60 nM for each siRNA). Cells were also transfected with control siR-
NA at the concentration of 180 nM. 48 h later cell proliferation was
determined by the MTT assay (Sigma, St. Louis, MO). Brieﬂy, 48 h
after transfection with siRNAs or plasmid encoding human or rat
striatin, cells were treated with the MTT solution (stock 5 mg/ml,
25 ll/well) and incubation was continued for 2 h to allow for
MTT reduction and formazan formation. Next, formazan crystals
were dissolved in 20% SDS/50% DMF pH 4.7 (95 ll/well) and absor-
bance was read at 570 and 650 nm on an ELISA-PLATE READER
(FLUOstar Omega). As a control we used untransfected cells and
cells transfected with control siRNA or empty plasmid.
2.4. Cell culture, siRNA, transfections
Human embryonal kidney cells (HEK293T) were cultured in
DMEM medium (Gibco) supplemented with 10% fetal bovine
serum (Gibco), streptomycin (100 lg/ml) and penicillin (100 U/
ml, Polfa) in a 5% CO2 – 95% air atmosphere. Cells were transfected
with a given siRNA or plasmid with the aid of Lipofectamine2000
(Invitrogen) according to manufacturer’s instructions. The com-
plexes of Lipofectamine2000 with DNA or RNA were prepared in
Opti-MEM Reduced-Serum Medium (Gibco). The ratio of Lipofect-
amine2000/nucleic acid (v/w) was 2/1. The ﬁnal concentration of
the siRNA was 150 nM for single siRNA transfections or 180 nM
for simultaneous transfection with siRNA for striatin, SG2NA and
zinedin (mix V1, 60 nM for each siRNA). Unless otherwise stated,
cells transfected with a given siRNA or plasmid overexpressing
STRN were analyzed 48 h post transfection.
2.5. siRNA sequences
siRNA sequences for striatin (STRN), SG2NA and zinedin (ZIN)
were designed with the aid of siDESIGN Center at www.dharma-
con.com. The sequences of the siRNA strands are shown in the
table below. siRNA strands were synthesized in the Department
of Bioorganic Chemistry, CMMS PAS and puriﬁed by HPLC. The
efﬁciency of STRN siRNAs were determined by Western blotting
of STRN protein levels in transfected HEK293T. The efﬁciency of
SG2NA and ZIN siRNAs were determined by real time RT-PCR
measurement of mRNA levels after HEK293T transfection with
siRNAs. We have identiﬁed that siRNA 632 for STRN, siRNA 769
for SG2NA and siRNA 3170 for ZIN most efﬁciently silenced the
expression of a corresponding member of the striatin family.
The mixture of these siRNAs (mix V1) was used for simultaneous
inhibition of all three proteins.mRNA (accession #) siRNA sequence, start position on mRNAStriatin, NM_003162 (start position 632)
Sens 50 GCACAGAGGCUGAAGUUAATT
Antisens 50 UUAACUUCAGCCUCUGUGCTT
(start position 1061)
Sens 50 GGUCAAAACUACAAGAUAUTT
Antisens 50 AUAUCUUGUAGUUUUGACCTT
(start position 1187)
Sens 50 CAGAUGAAGUGGAAGCAUUTT
Antisens 50 AAUGCUUCCACUUCAUCUGTTSG2NA, NM_001083893.1 (start position 769)
Sens 50 gAA gUA ggU UAU AcA gAU ATT
Antisens 50 UAU cUg UAU AAc cUA cUU cTT
(start position 909)
Sens 50 gcA AAA ggg AcA AgA AAU ATT
Antisense 50 UAU UUc UUg Ucc cUU UUg cTT
(start position 2232)
Sense 50 cAg cAA gAc AUg UgU gcA ATT
Antisense 50 UUg cAc AcA UgU cUU gcU gTT(continued)mRNA (accession #) siRNA sequence, start position on mRNAZinedin, NM_013403.2 (start position 384)
Sense 50 gAU cAA gAU gcU AgA gUA UTT
Antisense 50 AUA cUc UAg cAU cUU gAU cTT
(start position1080)
Sense 50 Ucg ggU cAA AcU ccA Agg cTT
Antisense 50 gcc UUg gAg UUU gAc ccg ATT
(start position 3170)
Sense 50 cAA UAA Acc cUU Ugg AgU ATT
Antisense 50 UAc Ucc AAA ggg UUU AUU gTTControl siRNA Sense 50ACAUGAAGCAGCACGACUUTT 30Antisense 50AAGUCGUGCUGCUUCAUGUTT2.6. Western blotting and immunoprecipitation
For Western blotting experiments HEK293T cells either non-
transfected or transfected with a speciﬁc siRNA or plasmid (in
the case of phospho-MAP2 analysis) were grown on 6-well plates
to a conﬂuency of about 80–90%. Cells were lysed in TBS buffer
containing 1%Triton X-100, supplemented with Complete prote-
ase inhibitor cocktail (Roche) and PhosStop phosphatase inhibi-
tor cocktail (Roche). Cell lysis was carried out for 15 min on ice
with occasional vortexing. Insoluble material was centrifuged
for 10 min (13000 rpm at 4 C) and clear supernatants were
transferred to new tubes. Protein concentration was measured
by DC Protein Assay Kit I (Bio Rad) according to manufacturer’s
instructions. The lysates were boiled in SDS sample buffer (0.4%
SDS, 5% b-mercaptoethanol, 0.008% bromophenol blue, 50 mM
Tris pH 6.8, 10% glicerol). Next, 30 lg of total cellular protein
was separated by SDS–PAGE in hand made 4% stacking/8% resolv-
ing gel. Resolved proteins were electro-transferred (semi-dry) to
nitrocellulose membrane (1.5 mA/cm2), which was blocked in
5% non-fat dry milk/TBS or 5% BSA/TBS (for phospho-MAP2 Wes-
tern blotting) for 1 h at room temperature. Membrane was
probed overnight at 4 C with primary antibodies diluted
1:1000 in 5% BSA/TBS and subsequently with goat anti-mouse
or goat anti-rabbit secondary antibodies conjugated with AP
(Santa Cruz) for 45 min at room temp. Membranes were
visualized by chemiluminescence (LumiPhos™ WB, Thermo
Scientiﬁc).
For Western blotting of phospho-MAP2, 70  104 HEK 293T
cells were seeded on each well of 6-well plate. 24 h later, cells were
transfected with STRN siRNAs (632, 1061, 1187) at the concentra-
tion of 100 nM. 48 h post transfection cells were lysed and phos-
pho-MAP2 was Western blotted as described above.
For immunoprecipitation experiments HEK293T cells were
lysed with 1% NP40/TBS supplemented with Complete protease
inhibitor cocktail (Roche) as described above. Supernatants were
precleared with protein A or G agarose for 1 h at 4 C (50 ll of
protein A(G)-beads per 1 ml of cell lysate). Beads were then
removed by centrifugation and lysates (containing approximately
1 mg of total cellular protein) were incubated overnight at 4 C
with an immunoprecipitating antibody (2 lg) or non-speciﬁc nor-
mal rabbit or mouse IgG. Subsequently, protein/antibody com-
plexes were isolated with protein A- or G-agarose for 2 h at
4 C. After 5–6 washes with lysis buffer, the beads were boiled
for 10 min in SDS sample buffer (0.4% SDS, 5% b-mercaptoethanol,
0.008% bromophenol blue, 50 mM Tris pH 6.8, 10% glicerol),
released proteins were separated by SDS/PAGE and visualized as
described above. For reprobing, membranes were stripped with
a stripping buffer (1.5% Glycine, 0.1% SDS, 1% Tween 20, pH
2.2) for 20 min at RT.
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HEK293T cells were seeded on a 6-well plate (7  105 cells/
well). 24 h later cells were transfected with 180 nM of a given siR-
NA. 48 h after transfection cells were lysed with TriPure Isolation
Reagent (Roche) and total RNA was isolated according to manufac-
turer’s instructions. RNA concentration was determined by UV
absorption using ND-1000 spectrophotometer (NanoDrop). RT-
PCR Samples were prepared with the aid of LightCycler RNA
Ampliﬁcation Kit SYBR Green I kit (Roche). Each sample contained
250 ng of total RNA, 2 mMMgCl2, 2 ll of 5xSYBR Green, 0.25 lM of
forward and reverse primer, 0.2 ll of enzyme mix. Total sample
volume was 10 ll. Expression of SG2NA and Zinedin mRNAs was
normalized against TBP mRNA, which was used as a reference.
RNA from HEK293T transfected with the control siRNA served as
a control.mRNA Primer Sequence Product
size [bp]hSG2NA SG2NAFwd 50-AACAAGATTTGCTTGGACAG-30 143
SG2NARev 50-TGAGCTTGACATTAAGATGTG-30hZINEDIN ZINFwd 50-CCCTGAACTCCCTGTATATC-30 146
ZINRev 50-GTAGAACCAAACAAGAGAGTGA-30tbp TBPFwd 50-TGCACAGGAGCCAAGAGTGAA-30 132
TBPRev 50-CACATCACAGCTCCCCACCA-30Fig. 1. (a) Western blot analysis of striatin expression. Cells were lysed, electro-
phoresed and electrotransferred to nitrocellulose membrane, which was probed
with anti-striatin mouse mAb (0.25 lg/ml) followed with goat anti-mouse perox-
idase-conjugated secondary Ab (0.2 lg/ml). 1 – Mouse brain (10 lg of total protein,
positive control); 2 – HUVECs (20 lg of total protein); 3 – Jurkat cells (20 lg of total
protein); 4 – HEK293T cells (30 lg of total protein). (b) Coimmunoprecipitation of
endogenous striatin and PP2Ac in HEK293T cells. 1 – input; 2 – IP of PP2Ac (mouse
mAb); 3 – IP with control mouse IgG. (c) Coimmunoprecipitation of endogenous
striatin and PP2Ac in HEK293T and HeLa cells. 1 – HEK293T input; 2 – HeLa input; 3
– HEK293T IP of striatin; 4 – HeLa IP of striatin; 5 – HEK293T IP with control IgG; 6
– HeLa IP with control IgG. (d) Coimmunoprecipitation of recombinant myc-tagged
rat striatin and endogenous PP2Ac in HEK293T cells. 1 – input; 2 – IP of myc-tagged
striatin in cells transfected with myc-tagged striatin; 3 – IP with anti-myc Ab in
cells transfected with empty vector (control); 4 – IP with control IgG in cells
transfected with myc-tagged striatin (control).Samples were ampliﬁed in the LightCycler 1.0 Instrument (Roche)
using the following steps: reverse transcription at 55 C for 10 min
followed by 45 ampliﬁcation cycles (95 C 0 s, 59 C 10 s, 72 C 8 s).
Finally, speciﬁcity of ampliﬁed products were evaluated by Tm
analysis (ﬂuorescence measurement in samples heated from 65 C
to 95 C with the heat rate of 0.1 C/s) using Light Cycler Software
4.05 (Roche). SG2NA or Zinedin mRNA expression changes in cells
transfected with a given siRNA were calculated usingDDCt method.
Data shown represent average values ± standard deviation from 3
experiments.
2.8. Microtubules stability assay
HEK293T cells were seeded on 6 well plates and transfected
with a striatin siRNA (150 nM) or a plasmid encoding striatin
(3 lg DNA/well). 48 h after transfection, cells were washed once
with PHEM buffer (6 mM PIPES, 2.5 mM HEPES, 0.5 mM EGTA,
0.6 mM MgCl2, pH7.0) and subsequently cytoskeletons were
extracted in 0.75% Triton X-100/PHEM buffer supplemented with
Complete protease inhibitor cocktail (Roche) and PhosStop
phosphatase inhibitor cocktail (Roche). Extraction was carried
out for 5 min at room temperature, 1 ml of 0.75% Triton X-100/
PHEM buffer was used per 1 well of 6-well plate. Extracted cyto-
skeletons were isolated by ultracentrifugation 30 min,
100000  g at 25 C (Beckman L8-80 M). Pellets were solubilized
at 37 C overnight in the same volume of SDS sample buffer. The
amount of microtubules was determined by Western blotting
using anti a-tubulin mAb (clone B-5-1-2, Sigma). After membranes
visualization (chemiluminescence), tubulin band intensities were
determined by densitometry. As internal controls, we used
HEK293T treated with 50 lM taxol (stabilizes MTs) or 20 lM noco-
dazole (disrupts MTs) for 3 h at 37 C, which were processed as
above.
2.9. Statistical analysis
Statistical signiﬁcance of the data was determined by Shapiro–
Wilk test (analysis of normality) followed by ANOVA (variance
analysis). Next, the differences between compared mean valueswere analyzed by post hoc Tukey’s HSD (Honestly Signiﬁcant Dif-
ference) test, to ﬁnd mean values that are signiﬁcantly different
from each other. All statistical analyses were done using Statistica
ver. 8.0 software (StatSoft Inc., Tulsa, OK). A value of P < 0.05 was
considered to be statistically signiﬁcant.
3. Results and discussion
3.1. Striatin is expressed in HEK293T cells and associates with PP2A
In the search for novel scaffold proteins involved in protein
phosphatase 2A (PP2A) signaling, we investigated whether
HEK293T cells, which are derived from human embryonic kidney,
express striatin, which is a prototypical member of the striatin
family of proteins. As shown in Fig. 1a, Western blot analysis of
HEK293T lysates with a mouse mAb (BD Pharmingen) allowed us
to detect a band with the apparent molecular weight of 110kD. A
band of the same size was found in the mouse brain lysate that
was used as a positive control. We also detected striatin in human
endothelial and Jurkat cells (Fig. 1a). We have conﬁrmed the pres-
ence of striatin in human and mouse platelets and megakaryocytes
as well as in CHO and HeLa cells (not shown). This conﬁrms that
striatin is expressed in multiple cell types rather than being
restricted to neuronal tissue. To further conﬁrm the expression of
striatin in HEK293T cells, we performed Western blotting and
probed for striatin in HEK293T cell lysates using a rabbit polyclonal
antibody. Again, a speciﬁc band was detected at 110kDa, corre-
Fig. 2. Localization of endogenous striatin in HEK293T, human platelets and CHO cells. (a) and (b) HEK293T immunostained for striatin only (anti-striatin mouse mAb, BD
Pharmingen (2.5 lg/ml), followed with goat anti-mouse AlexaFluor 488-conjugated Ab (2 lg/ml)). (c) and (d) Colocalization of striatin and microtubules in HEK293T cells.
Cells were stained with anti-striatin mouse mAb (BD Pharmingen, 2.5 lg/ml) followed with goat anti-mouse AlexaFluor 488-conjugated Ab (2 lg/ml). Tubulin was visualized
with anti-b tubulin rabbit mAb AlexaFluor 555-conjugated. (e) Resting and activated platelets immunostained for striatin only. Platelets were incubated at 4 C for 45 min or
treated with nocodazole (5 lM, 45 min) before staining. (f) Colocalization of striatin and microtubules in blood platelets. Cells were stained with anti-striatin mouse mAb (BD
Pharmingen, 2.5 lg/ml) followed with goat anti-mouse AlexaFluor 546-conjugated Ab (1 lg/ml). Tubulin was visualized with anti-a tubulin mouse mAb FITC-conjugated
(Sigma). (g) Colocalization of striatin and microtubules in CHO cells. Midbodies are indicated with arrows. Immunostaining as described in c and d.
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is expressed in HEK293T cells.
Striatin, SG2Na and zinedin have previously been shown to
associate with the catalytic subunit of protein phosphatase 2A
[5]. Therefore, they are considered to form a novel class of B regu-
latory subunits that govern PP2A substrate speciﬁcity and/or cellu-
lar localization. We next investigated whether endogenously
expressed striatin stably associates with a catalytic subunit of
PP2A, PP2Ac, in HEK293T cells. PP2Ac was immunoprecipitated
from cell lysates using a mouse mAb, and the resulting precipitate
was probed for striatin. As demonstrated in Fig. 1b, the immuno-
precipitate of PP2Ac contains a detectable amount of striatin
(Fig. 1b, lane 2). In the control sample, which was immunoprecip-
itated with mouse IgG, we did not detect a band at 110kDa (Fig. 1b,
lane 3). In a reciprocal experiment performed in HEK293T and
HeLa cells, we have conﬁrmed that PP2Ac is present in the immu-
noprecipitate of striatin (Fig. 1c, lanes 3 and 4). Thus, we conclude
that in HEK293T and HeLa cells endogenous striatin and PP2Ac
form a stable complex. Finally, we detected striatin/PP2Ac protein
complex in human platelets and CHO cells (Fig. 1S, supplemen-
tary). In addition, we assessed whether recombinant striatinassociates with endogenous PP2Ac. A myc-tagged full-length rat
striatin was overexpressed in HEK293T cells and immunoprecipi-
tated with an anti-myc mAb. Next, the precipitate was immuno-
blotted for PP2Ac. Surprisingly, we did not observe an association
between recombinant myc-tagged rat striatin and endogenous
PP2Ac in HEK293T cells (Fig. 1d). This suggests that the formation
of the striatin/PP2Ac complex may be tightly regulated in the cells.
3.2. Striatin colocalizes with microtubules in HEK293T
Although several lines of evidence suggest that striatin (as well
as SG2NA and zinedin) may be involved in cytoskeletal organiza-
tion, there are no reports showing colocalization of striatin with
any cytoskeletal structures. To date, immunochemical and immu-
noﬂuorescence studies have demonstrated that striatin and SG2NA
localize predominantly in the cytosol and cell membranes of endo-
thelial and epithelial cells [8,11,13,14]. In neurons, these two pro-
teins localize in the somato-dendritic compartment, particularly in
dendritic spines [23].
We investigated the cellular localization of striatin in HEK293T
cells by immunoﬂuorescence. Striatin was detected using a mouse
Fig. 2 (continued)
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tern showing tube-like structures (Fig. 2a). After staining the cells
for microtubules using an anti b-tubulin rabbit mAb, we observed
colocalization between tubulin and striatin. This colocalization is
particularly clear in cellular regions containing bundles of microtu-
bules (Fig. 2c and d). As shown on Fig. 2b, striatin seems to associ-
ate with structures resembling mitotic spindle. We have also
conﬁrmed colocalization of striatin and MTs in human plateletsand in CHO cells. Immunostaining of striatin in resting and acti-
vated platelets revealed that striatin almost exclusively colocalizes
with microtubules that form a very characteristic circumferential
ring (Fig. 2e and f). Interestingly, staining pattern of platelet stria-
tin changed dramatically upon exposure to agents that induce
microtubules depolymerization, i.e. low temperature or nocodaz-
ole (Fig. 2e). Striatin also colocalized with microtubules in CHO
cells, particularly in the midbody area of dividing cells (Fig. 2g).
Fig. 3. Coimmunoprecipitation of endogenous striatin and a-tubulin in HEK293T cells. Panel a: 1 – input; 2 – IP of striatin (rabbit polyclonal Ab); 3 – IP with control IgG. Panel
b: 1 – input; 2- IP of a-tubulin (mouse mAb); 3 – IP with control IgG.
Fig. 4. Effect of striatin downregulation on phosphorylation of MAP2 in HEK293T.
Cells were transfected with a given siRNA. 48 h later, cells were lysed and phospho-
MAP2 was detected with anti p-Ser136 antibodies. 1 – HEK293T cells transfected
with control siRNA; 2–4 – cells transfected with siRNA that inhibit expression of
striatin (1187 siSTRN, 1061 siSTRN, 632 siSTRN, respectively); 5 – untreated
HEK293T cells.
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microtubules in the cytoplasm of HEK293T cells, human platelets
and CHO cells.
Having observed that striatin colocalizes to some extent with
microtubules in human embryonic kidney cells, we investigated
whether striatin can associate with tubulin. Striatin was immuno-
precipitated from HEK293T cells using rabbit polyclonal antibod-
ies. Subsequently, the striatin precipitate was immunoblotted for
the presence of a-tubulin. As shown in Fig. 3a, a-tubulin was
detected in striatin immunoprecipitate (lane 2). However, tubulin
was also found in the IgG control sample (lane 3). We obtained
similar results when probing striatin immunoprecipitate for b-
tubulin (not shown). This suggests a non-speciﬁc association
between tubulin and the striatin immunoprecipitate. In a recipro-
cal experiment, we have pulled down a-tubulin and the resulting
immunoprecipitate was blotted for the striatin. As shown on
Fig. 3b, we were unable to detect striatin in the a-tubulin immuno-
precipitate. Therefore, we cannot unequivocally conﬁrm the for-
mation of a striatin/tubulin complex.
3.3. Striatin is involved in the regulation of MAP2 phosphorylation
Microtubule-associated proteins are responsible for the regula-
tion of microtubule stability in animal and plant cells [24]. This
regulation is governed by the phosphorylation/dephosphorylation
of speciﬁc MAPs. It has previously been demonstrated that PP2A
is responsible for regulating the phosphorylation of MAP2
[25,22]. Therefore, we investigated whether striatin, through its
association with PP2Ac and its colocalization with MTs, might con-
trol MAP2 phosphorylation. We modulated (down- or upregulated)
the expression of striatin and assessed the effects on MAP2 phos-
phorylation at the serine residue at position 136. Using RNA inter-
ference, we decreased the expression of endogenous striatin in
HEK293T cells. With the most efﬁcient siRNA (siSTRN 632), we
achieved approximately 80% inhibition at the protein level
(Fig. 2S, supplementary data). Interestingly, the downregulation
of striatin protein in HEK293T cells caused a signiﬁcant increase
in MAP2 phosphorylation at Ser136 (Fig. 4, lanes 2, 3 and 4) in
comparison to untreated cells or cells treated with control siRNA
(Fig. 4, lanes 1 and 5). This effect seems to be striatin-speciﬁc
because in cells transfected with control siRNA, the amount of
phosphorylated MAP2 is comparable to that in untreated HEK293T
cells. Overexpression of either full length human or rat striatin in
HEK293T had no effect on the phosphorylation of MAP2 at
Ser136. This result is consistent with our observation that recom-
binant striatin does not form a complex with endogenous PP2Ac.
We also investigated whether the modulation of striatin expres-
sion affects the phosphorylation of tau. Neither the downregula-
tion nor the overexpression of striatin produced an observable
change in tau phosphorylation at Ser396 (Fig. 3S, supplementary
data). Because striatin has no enzymatic activity, including phos-
phatase activity, these results suggest that striatin targets PP2Ac
to MAP2. PP2Ac may then directly dephosphorylate MAP2 and thusregulate its biological activity. This is consistent with our data
showing that MAP2 becomes hyperphosphorylated upon striatin
downregulation.
3.4. Downregulation of striatin induces microtubule depolymerization
MAP2 is involved in the regulation of microtubule dynamics
and assembly. Dephosphorylated MAP2 binds tightly to MTs and
stabilizes them. Conversely, hyperphosphorylated MAP2 dissoci-
ates from MTs, promoting their disassembly [19]. Therefore, we
investigated whether striatin downregulation, which causes
MAP2 hyperphosphorylation, affects MT stability. HEK293T cells
transfected with control siRNA or siSTRN 632 were lysed, and the
cytoskeleton fraction containing polymerized microtubules was
isolated by ultracentrifugation. Cytoskeleton pellets were then sol-
ubilized in SDS sample buffer, electrophoresed (SDS–PAGE) and
blotted for a-tubulin. The relative amounts of tubulin in each sam-
ple were assessed based on densitometry analysis of Western
blots. As shown in Fig. 5, inhibition of striatin expression in
HEK293T cells transfected with siSTRN 632 (Fig. 5, lane 3) caused
reduced the amount of polymerized MTs by approximately 30%
compared to cells transfected with control siRNA (Fig. 5, lane 2)
and by approximately 20% compared with untreated cells (Fig. 5,
lane 1). In a control experiment, we used taxol and nocodazole,
agents that are known to stabilize and depolymerize microtubules,
respectively. Fig. 5, lane 4 shows that taxol strongly stabilizes MTs
in HEK293T cells, whereas nocodazole caused signiﬁcant depoly-
merization of microtubules. Together, these results indicate that
striatin may be involved in the regulation of MT stability, likely
by controlling MAP2 phosphorylation. As expected, the overex-
pression of either rat or human full length striatin caused no
Fig. 5. Effect of striatin downregulation on microtubules stability in HEK293T. 48 h
after transfection with a given siRNA cells were lysed and cytoskeleton fraction was
extracted. The relative amount of MTs in each cytoskeleton sample was determined
by Western blotting with anti a-tubulin antibody, followed by densitometry
analysis (average values ± S.D. from 2 experiments are shown). 1 – untreated
HEK293T; 2 – cells transfected with control siRNA; 3 – cells transfected with 632
siSTRN; 4 – cells treated with taxol (50 lM) for 3 h before cytoskeleton extraction.
The numbers at the bottom of data bars represent relative amount of polymerized
microtubules.
Fig. 6. Effect of striatin downregulation on HEK293T proliferation. HEK293T were
transfected with a given siRNA and 48 h later the relative number of live cells were
measured by MTT assay. Lipofectamine – cells treated with lipofectamine only; ctrl
siRNA – cells transfected with control siRNA; 632 siSTRN, 1061 siSTRN, 1187 siSTRN
– cells transfected with a single siRNA that inhibits the expression of striatin; mix
V1 – cells transfected with a mixture of 3 siRNAs that downregulate the expression
of striatin, SG2NA and zinedin. Statistical analysis (Tukey’s test) is also shown.
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data).
3.5. Downregulation of striatin, SG2NA and zinedin inhibits
proliferation in HEK293T cells and causes the accumulation of cells in
G0/G1
Microtubules play important roles during the cell cycle, partic-
ularly in mitosis. They form the mitotic spindle and are responsible
for the mitotic checkpoint and the proper segregation of DNA into
daughter cells. Segregation of genetic material depends on precise
control of the polymerization and depolymerization of MTs. Even
subtle alterations in MT stability or dynamics can have deleterious
effects leading to cell cycle arrest, mitotic block, inhibition of cellTable 1
Effect of striatin, SG2NA and zinedin downregulation on a distribution of HEK293T in th
transfected with the mixture of three siRNAs (mix V1). The percentage of cells in each ph
Untreated cells (mean ± S.D.) ctrl siRNA s
G0/G1 phase 33.7 ± 1.0 35.6 ± 0.1 3
S phase 59.5 ± 2.7 57.4 ± 1.2 5
G2/M phase 6.8 ± 1.7 7.0 ± 1.1proliferation and, ﬁnally, cell death [26]. Therefore, we examined
whether the downregulation of striatin would affect HEK293T cell
proliferation. Cells were transfected with a given striatin siRNA
(632, 1061 or 1187 siSTRN, at 150 nM), and the relative number
of viable cells was determined 48 h later with the MTT assay. As
shown in Fig. 6, inhibition of striatin expression reduced the prolif-
eration of HEK293T cells by approximately 15% compared to cells
transfected with control siRNA. The striatin family members (stri-
atin, SG2NA and zinedin) are highly homologous at the levels of
both amino-acid sequence and molecular structure. They all bind
the catalytic subunit of PP2A, indicating that they may have redun-
dant cellular functions. Therefore, we investigated whether the
simultaneous downregulation of striatin, SG2NA and zinedin in
HEK293T cells would produce a more pronounced effect on cell
proliferation. siRNAs were designed to speciﬁcally downregulate
the expression of SG2NA and zinedin. Their silencing potency
was evaluated using real-time RT PCR (Fig. 5S, supplementary
data). The most efﬁcient siRNAs for SG2NA (siRNA 769) and zin-
edin (siRNA 3170) reduced mRNA expression by 65% and 47%,
respectively. The mixture of these siRNAs with siSTRN 632 (mix
V1) was transfected into HEK293T cells, and cell viability was ana-
lyzed 48 h later. We observed that the simultaneous downregula-
tion of striatin, SG2NA and zinedin resulted in approximately
30% inhibition of proliferation in HEK293T cells compared to cells
transfected with control siRNA (Fig. 6). This antiproliferative effect
is statistically signiﬁcant with P < 0.01. We also investigated the
effect of downregulating striatin, SG2NA and zinedin on cell-cycle
progression. Flow cytometry analysis of DNA content revealed that
the separate inhibition of striatin, SG2NA or zinedin had no signif-
icant effect on the distribution of HEK293T cells through the cell
cycle. However, the simultaneous downregulation of all striatin
family members (using mix V1) resulted in the accumulation of
HEK293T cells in the G0/G1 phase. In this experiment, 42.3% of
cells transfected with mix V1 were in the G0/G1 phase, compared
to 33.7% and 35.6% for untreated cells and cells transfected with
control siRNA, respectively (Table 1). Downregulation of striatin,
SG2NA or zinedin did not induce cell-cycle arrest in the G2/M
phase.
Striatin belongs to the novel B000 family of regulatory subunits
that govern the substrate speciﬁcity and cellular localization of
the PP2A A/C core dimer [5]. Thus, in the presence of striatin or
another B regulatory subunit, the fully functional PP2A heterotri-
mer is formed and precisely targeted to speciﬁc protein substrates.
Consequently, PP2A can modulate the biological activity of these
proteins by dephosphorylating phosphoserine and/or phospho-
threonine residues. Our data suggest a novel role for striatin: the
regulation of microtubule stability in HEK293T cells. Several obser-
vations presented here corroborate this hypothesis. We demon-
strate that striatin colocalizes with microtubules in HEK293T and
other cells (platelets and CHO cells). In addition, we show that
the downregulation of striatin expression caused hyperphosphory-
lation of MAP2. MAP2 binds directly to microtubules and regulates
their dynamics, and the MAP2-MT binding depends on the phos-
phorylation of MAP2. Dephosphorylated MAP2 binds to and stabi-
lizes MTs, whereas hyperphosphorylated MAP2 dissociates from
MTs, inducing their disassembly [19]. It has previously been shown
that PP2A is responsible for MAP2 dephosphorylation [22]. Wee cell cycle. For simultaneous inhibition of striatin, SG2NA and zinedin, cells were
ase ± S.D. is shown.
iRNA STRN siRNA SG2NA siRNA zinedin mix V1
7.5 ± 0.5 37.9 ± 2.0 38.2 ± 2.9 42.3 ± 1.0
5.6 ± 2.1 55.7 ± 3.7 55.1 ± 4.3 50.2 ± 0.3
6.9 ± 1.6 6.4 ± 1.7 6.7 ± 1.3 7.5 ± 0.7
230 J. Kaz´mierczak-Baran´ska et al. / FEBS Letters 589 (2015) 222–230conﬁrm that endogenous striatin associates with PP2Ac in
HEK293T cells. This raises the possibility that the striatin/PP2A
complex is involved in MAP2 dephosphorylation. However, this
would require an interaction (either direct or indirect) between
striatin and MAP2, allowing PP2A to dephosphorylate MAP2. Such
an interaction between striatin and MAP2 has not yet been con-
ﬁrmed. Hyperphosphorylation of MAP2 induces its dissociation
fromMTs and results in MT depolymerization. Indeed, upon down-
regulation of striatin, which results in MAP2 hyperphosphorylation
in HEK293T cells, we observed a reduction in the amount of poly-
merized microtubules. Finally, striatin downregulation inhibited
the proliferation of HEK293T cells and caused cell-cycle arrest in
the G0/G1 phase.
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